Laval Chan

1.3k total citations
27 papers, 968 citations indexed

About

Laval Chan is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Laval Chan has authored 27 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Organic Chemistry and 9 papers in Molecular Biology. Recurrent topics in Laval Chan's work include HIV/AIDS drug development and treatment (15 papers), Cytomegalovirus and herpesvirus research (7 papers) and HIV Research and Treatment (6 papers). Laval Chan is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), Cytomegalovirus and herpesvirus research (7 papers) and HIV Research and Treatment (6 papers). Laval Chan collaborates with scholars based in Canada, United States and United Kingdom. Laval Chan's co-authors include Jean Bédard, Constantin G. Yannopoulos, M.M. Cherney, Michael N.G. James, Meitian Wang, Nghe Nguyen‐Ba, Darius Bilimoria, B.K. Biswal, Richard C. Bethell and Moulay Hicham Alaoui-Ismaili and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Chemical Communications.

In The Last Decade

Laval Chan

27 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laval Chan Canada 16 427 384 332 284 274 27 968
Amartya Basu United States 23 166 0.4× 172 0.4× 457 1.4× 439 1.5× 104 0.4× 40 1.2k
Nathalie Goudreau Canada 25 371 0.9× 492 1.3× 687 2.1× 294 1.0× 206 0.8× 42 1.5k
Julie Q. Hang United States 16 238 0.6× 340 0.9× 257 0.8× 118 0.4× 228 0.8× 20 718
Dawn L. Hall United States 14 258 0.6× 279 0.7× 508 1.5× 105 0.4× 234 0.9× 16 930
Mirko Brunetti Italy 16 543 1.3× 222 0.6× 874 2.6× 240 0.8× 303 1.1× 20 1.5k
Marc‐André Poupart Canada 18 550 1.3× 346 0.9× 520 1.6× 391 1.4× 303 1.1× 29 1.3k
Ginette McKercher Canada 14 495 1.2× 502 1.3× 196 0.6× 164 0.6× 288 1.1× 30 982
Gulrez Fazal Canada 13 371 0.9× 267 0.7× 207 0.6× 256 0.9× 275 1.0× 16 810
Makonen Belema United States 13 749 1.8× 322 0.8× 280 0.8× 292 1.0× 558 2.0× 18 1.2k
Van N. Nguyen United States 12 639 1.5× 260 0.7× 219 0.7× 303 1.1× 498 1.8× 14 1.1k

Countries citing papers authored by Laval Chan

Since Specialization
Citations

This map shows the geographic impact of Laval Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laval Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laval Chan more than expected).

Fields of papers citing papers by Laval Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laval Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laval Chan. The network helps show where Laval Chan may publish in the future.

Co-authorship network of co-authors of Laval Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Laval Chan. A scholar is included among the top collaborators of Laval Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laval Chan. Laval Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biswal, B.K., Meitian Wang, M.M. Cherney, et al.. (2006). Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition. Journal of Molecular Biology. 361(1). 33–45. 61 indexed citations
2.
Biswal, B.K., M.M. Cherney, Meitian Wang, et al.. (2005). Crystal Structures of the RNA-dependent RNA Polymerase Genotype 2a of Hepatitis C Virus Reveal Two Conformations and Suggest Mechanisms of Inhibition by Non-nucleoside Inhibitors. Journal of Biological Chemistry. 280(18). 18202–18210. 152 indexed citations
3.
Lachance, Hugo, Annie St‐Pierre, Constantin G. Yannopoulos, et al.. (2005). Design and synthesis of a potent macrocyclic 1,6-napthyridine anti-human cytomegalovirus (HCMV) inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(6). 1693–1695. 22 indexed citations
4.
5.
Meerovitch, Karen, et al.. (2003). Thiophene‐Based Vitronectin Receptor Antagonists. ChemInform. 34(21). 1 indexed citations
6.
Meerovitch, Karen, Lorraine Leblond, Brigitte Grouix, et al.. (2003). A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascular Pharmacology. 40(2). 77–89. 63 indexed citations
7.
Wang, Meitian, Kenneth Ng, M.M. Cherney, et al.. (2003). Non-nucleoside Analogue Inhibitors Bind to an Allosteric Site on HCV NS5B Polymerase. Journal of Biological Chemistry. 278(11). 9489–9495. 159 indexed citations
8.
Meerovitch, Karen, et al.. (2003). Thiophene-based vitronectin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(3). 503–506. 9 indexed citations
9.
Reddy, T. Jagadeeswar, Laval Chan, Mélanie Proulx, et al.. (2003). Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 13(19). 3341–3344. 12 indexed citations
10.
Rej, Rabindra, et al.. (2002). Novel nucleotide phosphonate analogues with potent antitumor activity. Bioorganic & Medicinal Chemistry Letters. 12(21). 3063–3066. 29 indexed citations
11.
Chan, Laval, et al.. (2001). Design and synthesis of new potent human cytomegalovirus (HCMV) inhibitors based on internally hydrogen-bonded 1,6-naphthyridines. Bioorganic & Medicinal Chemistry Letters. 11(2). 103–105. 9 indexed citations
12.
Chan, Laval, et al.. (2000). Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(13). 1477–1480. 13 indexed citations
13.
Chan, Laval, et al.. (2000). Substituted 1,6-naphthyridines as human cytomegalovirus inhibitors: conformational requirements. Bioorganic & Medicinal Chemistry Letters. 10(24). 2769–2770. 12 indexed citations
14.
Nguyen‐Ba, Nghe, et al.. (2000). Synthesis of N-1-oxypyrimidine 1,3-dioxolane and 1,3-oxathiolane nucleosides. Chemical Communications. 2311–2312. 2 indexed citations
15.
Nguyen‐Ba, Nghe, et al.. (2000). Synthesis and antiviral activities of N-9-oxypurine 1,3-Dioxolane and 1,3-oxathiolane nucleosides. Bioorganic & Medicinal Chemistry Letters. 10(19). 2223–2226. 15 indexed citations
16.
Chan, Laval, et al.. (1999). Isoquinoline-6-carboxamides as potent and selective anti-human cytomegalovirus (HCMV) inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(17). 2583–2586. 13 indexed citations
17.
Chan, Laval, Haolun Jin, Jean-François Lavallée, et al.. (1999). Discovery of 1,6-Naphthyridines as a Novel Class of Potent and Selective Human Cytomegalovirus Inhibitors. Journal of Medicinal Chemistry. 42(16). 3023–3025. 45 indexed citations
18.
19.
Mitchell, Helen, et al.. (1998). Design and synthesis of a novel class of nucleotide analogs with anti-HCMV activity. Bioorganic & Medicinal Chemistry Letters. 8(24). 3555–3560. 3 indexed citations
20.
Yuen, Leonard, et al.. (1998). Identification of novel nucleotide phosphonate analogs with potent anti-HCMV activity. Bioorganic & Medicinal Chemistry Letters. 8(24). 3561–3566. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amartya Basu Breakdown of academic impact, for papers by Nathalie Goudreau Breakdown of academic impact, for papers by Julie Q. Hang Breakdown of academic impact, for papers by Dawn L. Hall Breakdown of academic impact, for papers by Mirko Brunetti Breakdown of academic impact, for papers by Marc‐André Poupart Breakdown of academic impact, for papers by Ginette McKercher Breakdown of academic impact, for papers by Gulrez Fazal Breakdown of academic impact, for papers by Makonen Belema Breakdown of academic impact, for papers by Van N. Nguyen
Rankless by CCL
2026